218 related articles for article (PubMed ID: 37324256)
21. Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer.
Tan HL; Nyarko A; Duan SL; Zhao YX; Chen P; He Q; Zhang ZJ; Chang S; Huang P
Front Endocrinol (Lausanne); 2022; 13():987906. PubMed ID: 36714580
[TBL] [Abstract][Full Text] [Related]
22. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
23. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
[TBL] [Abstract][Full Text] [Related]
24. Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.
Gan XX; Li YY; Li SJ; Mo SS; Feng JH; Shen F; Cai WS; Lai YQ; Xu B
Front Oncol; 2021; 11():680873. PubMed ID: 34422633
[TBL] [Abstract][Full Text] [Related]
25. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
[TBL] [Abstract][Full Text] [Related]
26. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.
Jin P; Chen J; Dong Y; Zhang C; Chen Y; Zhang C; Qiu F; Zhang C; Huang P
Front Endocrinol (Lausanne); 2022; 13():993564. PubMed ID: 36060946
[TBL] [Abstract][Full Text] [Related]
28. The Underestimated Impact of Hashimoto Thyroiditis on Thyroid Papillary Carcinoma.
Harmantepe AT; Ozdemir K; Bayhan Z; Kocer B
Updates Surg; 2024 Jun; 76(3):1085-1089. PubMed ID: 38687448
[TBL] [Abstract][Full Text] [Related]
29. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
30. Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.
Lopes NMD; Lens HHM; da Silva Brito WA; Bianchi JK; Marinello PC; Cecchini R; Armani A; Cecchini AL
Clin Transl Oncol; 2022 Dec; 24(12):2366-2378. PubMed ID: 35902455
[TBL] [Abstract][Full Text] [Related]
31. Mutation of Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma Related Genes and the Screening of Candidate Genes.
Zhang L; Zhou L; Feng Q; Li Q; Ge M
Front Oncol; 2021; 11():813802. PubMed ID: 34993154
[TBL] [Abstract][Full Text] [Related]
32. Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto's Thyroiditis by Comprehensive Analysis.
Xi Z; Yang T; Huang T; Zhou J; Yang P
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137348
[TBL] [Abstract][Full Text] [Related]
33. Relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma in children and adolescents.
Zeng R; Zhao M; Niu H; Yang KX; Shou T; Zhang GQ; Yan XM
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7778-7787. PubMed ID: 30536322
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
[TBL] [Abstract][Full Text] [Related]
35. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
36. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
37. Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.
Park SH; Park CS; Kim YI; Nam-Goong IS; Kim YS; Lee JC; Choi JI; Park JW; Kim ES
Asian Pac J Cancer Prev; 2015; 16(6):2447-51. PubMed ID: 25824779
[TBL] [Abstract][Full Text] [Related]
38. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
39. Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients.
Graceffa G; Patrone R; Vieni S; Campanella S; Calamia S; Laise I; Conzo G; Latteri M; Cipolla C
BMC Endocr Disord; 2019 May; 19(Suppl 1):26. PubMed ID: 31142293
[TBL] [Abstract][Full Text] [Related]
40. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
